• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊椎动物烟碱型乙酰胆碱受体的多样性

Diversity of vertebrate nicotinic acetylcholine receptors.

作者信息

Millar Neil S, Gotti Cecilia

机构信息

Department of Neuroscience, Physiology and Pharmacology, University College London, London WC1E 6BT, UK.

出版信息

Neuropharmacology. 2009 Jan;56(1):237-46. doi: 10.1016/j.neuropharm.2008.07.041. Epub 2008 Aug 5.

DOI:10.1016/j.neuropharm.2008.07.041
PMID:18723036
Abstract

Nicotinic acetylcholine receptors (nAChRs) are pentameric neurotransmitter receptors. They are members of the Cys-loop family of ligand-gated ion channels which also include ionotropic receptors for 5-hydroxytryptamine (5-HT), gamma-aminobutyric acid (GABA) and glycine. Nicotinic receptors are expressed in both the nervous system and at the neuromuscular junction and have been implicated in several neurological and neuromuscular disorders. In vertebrates, seventeen nAChR subunits have been identified (alpha1-alpha10, beta1-beta4, gamma, delta and epsilon) which can co-assemble to generate a diverse family of nAChR subtypes. This review will focus on vertebrate nAChRs and will provide an overview of the extent of nAChR diversity based on studies of both native and recombinant nAChRs.

摘要

烟碱型乙酰胆碱受体(nAChRs)是五聚体神经递质受体。它们是半胱氨酸环家族配体门控离子通道的成员,该家族还包括5-羟色胺(5-HT)、γ-氨基丁酸(GABA)和甘氨酸的离子otropic受体。烟碱型受体在神经系统和神经肌肉接头中均有表达,并与多种神经和神经肌肉疾病有关。在脊椎动物中,已鉴定出17种nAChR亚基(α1-α10、β1-β4、γ、δ和ε),它们可以共同组装形成一个多样的nAChR亚型家族。本综述将聚焦于脊椎动物nAChRs,并基于对天然和重组nAChRs的研究,概述nAChR多样性的程度。

相似文献

1
Diversity of vertebrate nicotinic acetylcholine receptors.脊椎动物烟碱型乙酰胆碱受体的多样性
Neuropharmacology. 2009 Jan;56(1):237-46. doi: 10.1016/j.neuropharm.2008.07.041. Epub 2008 Aug 5.
2
Assembly and trafficking of nicotinic acetylcholine receptors (Review).烟碱型乙酰胆碱受体的组装与运输(综述)
Mol Membr Biol. 2008 May;25(4):279-92. doi: 10.1080/09687680802035675.
3
A review of experimental techniques used for the heterologous expression of nicotinic acetylcholine receptors.用于烟碱型乙酰胆碱受体异源表达的实验技术综述。
Biochem Pharmacol. 2009 Oct 1;78(7):766-76. doi: 10.1016/j.bcp.2009.06.015. Epub 2009 Jun 18.
4
Recent advances in understanding the structure of nicotinic acetylcholine receptors.理解烟碱型乙酰胆碱受体结构的最新进展。
IUBMB Life. 2009 Apr;61(4):407-23. doi: 10.1002/iub.170.
5
Assembly and subunit diversity of nicotinic acetylcholine receptors.烟碱型乙酰胆碱受体的组装与亚基多样性
Biochem Soc Trans. 2003 Aug;31(Pt 4):869-74. doi: 10.1042/bst0310869.
6
Nicotinic acetylcholine receptors: from structure to brain function.烟碱型乙酰胆碱受体:从结构到脑功能
Rev Physiol Biochem Pharmacol. 2003;147:1-46. doi: 10.1007/s10254-003-0005-1. Epub 2003 Mar 20.
7
Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity.肌肉和神经元烟碱型乙酰胆碱受体。结构、功能与致病性。
FEBS J. 2007 Aug;274(15):3799-845. doi: 10.1111/j.1742-4658.2007.05935.x.
8
Neuronal nicotinic receptors: from structure to pathology.神经元烟碱受体:从结构到病理学
Prog Neurobiol. 2004 Dec;74(6):363-96. doi: 10.1016/j.pneurobio.2004.09.006.
9
Structure and diversity of insect nicotinic acetylcholine receptors.昆虫烟碱型乙酰胆碱受体的结构与多样性
Pest Manag Sci. 2001 Oct;57(10):914-22. doi: 10.1002/ps.349.
10
Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors.多肽和肽毒素,烟碱型乙酰胆碱受体结合位点的放大镜。
Biochem Pharmacol. 2009 Oct 1;78(7):720-31. doi: 10.1016/j.bcp.2009.05.032. Epub 2009 Jun 6.

引用本文的文献

1
The Functional Topology of Phenylpiperazinium Agonists and Antagonists on the Nicotinic Acetylcholine Receptor Landscape: Pointing the Way for Future Therapeutic Management of Inflammation and Neuropathic Pain.苯基哌嗪鎓激动剂和拮抗剂在烟碱型乙酰胆碱受体图谱上的功能拓扑结构:为炎症和神经性疼痛的未来治疗管理指明方向
ACS Chem Neurosci. 2025 Aug 6;16(15):2901-2920. doi: 10.1021/acschemneuro.5c00216. Epub 2025 Jul 8.
2
Optimizing PCR amplification of GC-rich nicotinic acetylcholine receptor subunits from invertebrates.优化从无脊椎动物中富含GC的烟碱型乙酰胆碱受体亚基的PCR扩增
Biochem Biophys Rep. 2025 May 15;42:102052. doi: 10.1016/j.bbrep.2025.102052. eCollection 2025 Jun.
3
The Role of α7-Nicotinic Acetylcholine Receptors in the Pathophysiology and Treatment of Parkinson's Disease.
α7-烟碱型乙酰胆碱受体在帕金森病病理生理学及治疗中的作用
Int J Mol Sci. 2025 Mar 30;26(7):3210. doi: 10.3390/ijms26073210.
4
A Pharmacophore for Drugs Targeting the α4α4 Binding Site of the (α4)(β2) Nicotinic Acetylcholine Receptor.靶向(α4)(β2)烟碱型乙酰胆碱受体α4α4结合位点的药物药效团
J Neurochem. 2025 Feb;169(2):e70000. doi: 10.1111/jnc.70000.
5
Alcohol-induced liver injury is mediated via α4-containing nicotinic acetylcholine receptors expressed in hepatocytes.酒精性肝损伤是通过肝细胞中表达的含α4的烟碱型乙酰胆碱受体介导的。
Alcohol Clin Exp Res (Hoboken). 2025 Mar;49(3):515-525. doi: 10.1111/acer.15533. Epub 2025 Jan 23.
6
Nicotine-induced CHRNA5 activation modulates CES1 expression, impacting head and neck squamous cell carcinoma recurrence and metastasis via MEK/ERK pathway.尼古丁诱导的 CHRNA5 激活调节 CES1 表达,通过 MEK/ERK 通路影响头颈部鳞状细胞癌的复发和转移。
Cell Death Dis. 2024 Oct 29;15(10):785. doi: 10.1038/s41419-024-07178-4.
7
Protein networking: nicotinic acetylcholine receptors and their protein-protein-associations.蛋白质网络:烟碱型乙酰胆碱受体及其蛋白-蛋白相互作用。
Mol Cell Biochem. 2024 Jul;479(7):1627-1642. doi: 10.1007/s11010-024-05032-x. Epub 2024 May 21.
8
Explorations of Agonist Selectivity for the α9* nAChR with Novel Substituted Carbamoyl/Amido/Heteroaryl Dialkylpiperazinium Salts and Their Therapeutic Implications in Pain and Inflammation.新型取代氨基甲酰基/酰胺基/杂芳基二烷基哌嗪鎓盐对α9*烟碱型乙酰胆碱受体激动剂选择性的探索及其在疼痛和炎症中的治疗意义
J Med Chem. 2024 Jun 13;67(11):8642-8666. doi: 10.1021/acs.jmedchem.3c02429. Epub 2024 May 15.
9
Postsynaptic receptors regulate presynaptic transmitter stability through transsynaptic bridges.突触后受体通过突触桥调节突触前递质的稳定性。
Proc Natl Acad Sci U S A. 2024 Apr 9;121(15):e2318041121. doi: 10.1073/pnas.2318041121. Epub 2024 Apr 3.
10
The many enigmas of nicotine.尼古丁的诸多谜团。
Adv Pharmacol. 2024;99:327-354. doi: 10.1016/bs.apha.2023.08.001. Epub 2023 Oct 17.